The management of dyslipidemia in CKD: New analyses of an expanding dataset

American Journal of Kidney Diseases

Volumn 61, Issue 3, 2013, Pages 371-374

  Kasiske, Bertram L ^a   Wheeler, David C ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; ROSUVASTATIN; SIMVASTATIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DYSLIPIDEMIA; EVIDENCE BASED PRACTICE; GRAFT RECIPIENT; HEART DISEASE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY TRANSPLANTATION; LIPID METABOLISM; META ANALYSIS; PRACTICE GUIDELINE; REVIEW; SYSTEMATIC REVIEW;

EID: 84874026581     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.11.035     Document Type: Editorial

References (18)

1. A.S. Levey, P.E. de Jong, J. Coresh The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report Kidney Int 80 1 2011 17 28
2. K. Matsushita, M. van der Velde, B.C. Astor Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 9731 2010 2073 2081
3. M. van der Velde, K. Matsushita, J. Coresh Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality A collaborative meta-analysis of high-risk population cohorts Kidney Int 79 12 2011 1341 1352
4. R.T. Gansevoort, K. Matsushita, M. van der Velde Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes A collaborative meta-analysis of general and high-risk population cohorts Kidney Int 80 1 2011 93 104
5. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease Am J Kidney Dis 41 4 2003 S1 S91 (suppl 3)
6. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 19 2001 2486 2497
7. H. Holdaas, B. Fellström, A.G. Jardine Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 361 9374 2003 2024 2031
8. H. Holdaas, B. Fellström, E. Cole Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study Am J Transplant 5 12 2005 2929 2936
9. C. Wanner, V. Krane, W. Marz Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 3 2005 238 248
10. B.C. Fellstrom, A.G. Jardine, R.E. Schmieder Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 14 2009 1395 1407
11. C. Baigent, M.J. Landray, C. Reith The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
12. A. Upadhyay, A. Earley, J.L. Lamont, S. Haynes, C. Wanner, E.M. Balk Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis Ann Intern Med 157 4 2012 251 262
13. S.C. Palmer, J.C. Craig, S.D. Navaneethan, M. Tonelli, F. Pellegrini, G.F. Strippoli Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis Ann Intern Med 157 4 2012 263 275
14. H. Holdaas, A.G. Jardine, D.C. Wheeler Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial Kidney Int 60 2001 1990 1997
15. A.K. Gupta, C.L. Chang, B. Dahlof, N.R. Poulter, P.S. Sever Cardiovascular and all-cause mortality outcomes among hypertensive patients with moderate renal dysfunction in the ASCOT-LLA, and its extended follow-up J Hum Hypertens 25 2011 633 634
16. T.R. Pedersen, O. Faergeman, J.J. Kastelein High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL Study: a randomized controlled trial JAMA 294 19 2005 2437 2445
17. R. Collins, J. Armitage, S. Parish, P. Sleigh, R. Peto MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 9374 2003 2005 2016
18. C. Baigent, M. Landray, C. Leaper First United Kingdom Heart and Renal Protection (UK-HARP-I) Study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease Am J Kidney Dis 45 3 2005 473 484